TRV GP IV’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.3M | Hold |
16,859,075
| – | – | 52.85% | 1 |
|
|
2025
Q1 | $23.1M | Hold |
16,859,075
| – | – | 24.88% | 2 |
|
|
2024
Q4 | $52.1M | Hold |
16,859,075
| – | – | 64.97% | 1 |
|
|
2024
Q3 | $130M | Sell |
16,859,075
-2,342,400
| -12% | -$18M | 80.09% | 1 |
|
|
2024
Q2 | $165M | Hold |
19,201,475
| – | – | 81.48% | 1 |
|
|
2024
Q1 | $152M | Sell |
19,201,475
-162,500
| -0.8% | -$1.29M | 73.88% | 1 |
|
|
2023
Q4 | $192M | Hold |
19,363,975
| – | – | 77.88% | 1 |
|
|
2023
Q3 | $218M | Hold |
19,363,975
| – | – | 82.15% | 1 |
|
|
2023
Q2 | $64.3M | Hold |
19,363,975
| – | – | 58.09% | 1 |
|
|
2023
Q1 | $76.5M | Hold |
19,363,975
| – | – | 54.67% | 1 |
|
|
2022
Q4 | $140M | Hold |
19,363,975
| – | – | 59.7% | 1 |
|
|
2022
Q3 | $70.1M | Hold |
19,363,975
| – | – | 40.96% | 1 |
|
|
2022
Q2 | $87.7M | Hold |
19,363,975
| – | – | 57.68% | 1 |
|
|
2022
Q1 | $147M | Hold |
19,363,975
| – | – | 53.77% | 1 |
|
|
2021
Q4 | $212M | Hold |
19,363,975
| – | – | 60.92% | 1 |
|
|
2021
Q3 | $250M | Buy |
+19,363,975
| New | +$250M | 56.81% | 1 |
|